Supriya Lifescience Ltd. logo

Supriya Lifescience Ltd. (SUPRIYA)

Market Closed
12 Jun, 10:00
XNSE XNSE
977. 15
+40.15
+4.285%
31.19B Market Cap
25.94 P/E Ratio
4% Div Yield
709,530 Volume
0 Eps
937
Previous Close
Add Transaction
Day Range
952.55 995
Year Range
545.5 1,085
Want to track SUPRIYA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SUPRIYA closed Friday higher at ₹977.15, an increase of 4.285% from Thursday's close, completing a monthly decrease of -1.298% or -₹12.85. Over the past 12 months, SUPRIYA stock gained 29.7676%.
SUPRIYA pays dividends to its shareholders, with the most recent payment made on Oct 24, 2025. The next estimated payment will be in In 4 months on Oct 24, 2026 for a total of ₹1.
The last earnings report, released on Jun 02, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.2433%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).

SUPRIYA Chart

People also search for

Syngene International Ltd.
458.55
+2.3663%
Doms Industries Ltd.
2,291
+1.5784%
Rainbow Children's Medicare Pvt. Ltd.
1,365
+1.8733%
Medplus Health Services Ltd.
881.95
+0.6965%
Marksans Pharma Ltd.
252.37
+1.0167%

Supriya Lifescience Ltd. (SUPRIYA) FAQ

What is the stock price today?

The current price is ₹977.15.

On which exchange is it traded?

Supriya Lifescience Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is SUPRIYA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, the market cap is 31.19B.

Has Supriya Lifescience Ltd. ever had a stock split?

No, there has never been a stock split.

Supriya Lifescience Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Rajeev Kumar Jain CEO
XNSE Exchange
INE07RO01027 ISIN
India Country
515 Employees
4 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

Supriya Lifescience Limited is a prominent entity in the pharmaceutical sphere, specializing in the research and development, manufacturing, and international sales of bulk drugs and pharmaceutical chemicals. Established in the year 1987, the company has carved a niche for itself by offering a wide range of high-quality pharmaceutical products. Headquartered in Mumbai, India, Supriya Lifescience Limited has expanded its reach worldwide, catering to the needs of various markets with its innovative and effective healthcare solutions.

Products and Services

  • Anti-allergic: These products are designed to combat allergic reactions. Supriya Lifescience Limited provides a range of medications aimed at treating symptoms associated with allergies, helping to alleviate discomfort and improve the quality of life for individuals with allergic conditions.
  • Anti-asthmatic: The company offers medications that are specifically formulated to manage and treat asthma. These anti-asthmatic products help in controlling asthma symptoms, providing relief to those suffering from this chronic respiratory condition.
  • Decongestant: Decongestants are developed to relieve nasal congestion often caused by colds, flu, and allergies. Supriya Lifescience Limited's decongestant products help in clearing nasal passages, facilitating easier breathing.
  • Analgesic/Anti-pyretic/Anesthetic: This category includes medications that serve various purposes such as pain relief (analgesic), fever reduction (anti-pyretic), and numbness to prevent pain during procedures (anesthetic). The company's versatile range addresses the multifaceted needs of pain and symptom management.
  • Anti-hypertensive: Supriya Lifescience Limited provides medications that are designed to manage high blood pressure. These anti-hypertensive products play a critical role in preventing complications associated with hypertension, such as stroke and heart disease.
  • Anti-malarial: The company has developed effective solutions for the prevention and treatment of malaria. These anti-malarial products are crucial in combatting this mosquito-borne disease, especially in regions where malaria is endemic.
  • Vitamins: Recognizing the importance of micronutrients for overall health, Supriya Lifescience Limited manufactures a variety of vitamins that support various bodily functions and contribute to general well-being.
  • Xanthine derivatives: These compounds are used in the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD). The xanthine derivatives offered by Supriya Lifescience Limited help in relaxing the muscles around the airways and improving breathing.

Contact Information

Address: 207/208 Udyog Bhavan
Phone: 91 22 4033 2727